Exploiting Real-Time Genomic Surveillance Data To Assess 4CMenB Meningococcal Vaccine Performance in Scotland, 2015 to 2022

Exploiting Real-Time Genomic Surveillance Data To Assess 4CMenB Meningococcal Vaccine Performance in Scotland, 2015 to 2022

ABSTRACT The United Kingdom implemented the first national infant immunization schedule for the meningococcal vaccine 4CMenB (Bexsero) in September 2015, targeting serogroup B invasive meningococcal disease (IMD). Bexsero contains four variable subcapsular proteins, and postimplementation IMD survei...

Descrición completa

Detalles Bibliográficos
Main Authors: C. M. C. Rodrigues, L. MacDonald, R. Ure, A. Smith, J. C. Cameron, M. C. J. Maiden
Formato: Artigo
Idioma:English
Publicado: American Society for Microbiology 2023-04-01
Series:mBio
Subjects:
vaccination
Bexsero
4CMenB
breakthrough cases
genomics
WGS
Acceso en liña:https://journals.asm.org/doi/10.1128/mbio.00499-23

Internet

https://journals.asm.org/doi/10.1128/mbio.00499-23

Títulos similares